OTC: GNMSF - Genmab A/S

Yield per half year: -20.1%
Sector: Healthcare

Current price
237.28 $
Average price
313 $ +31.91%

Price based on EPS
313 $ +31.91%
10/10

Price based on EPS

Price = EPS * (1 + CAGR EPS) / (Key Rate * Excess Key Rate)
Key Rate = Key rate
Fair price = 313 $
Current price = 237.28 $ (difference = +31.91%)


Data

Discounted Cash Flow (Based on EBITDA)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount Ebitda(5) * (1 + Ebitda Yield) / (WACC - Ebitda Yield)
Company Value = ∑ (Future Ebitda / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = 2 199.09 $
Current price = 237.28 $ (difference = +826.79%)


Data

Discounted Cash Flow (Based on FCF)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount FCF(5) * (1 + FCF Yield) / (WACC - FCF Yield) ^ 5
Company Value = ∑ (FCF / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = 2 959.48 $
Current price = 237.28 $ (difference = +1 147.25%)


Data

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription